ReviewMedicine2026
Functional alterations of peripheral blood CD4+ T lymphocyte subsets in patients with Parkinson disease: A review.
Review in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Parkinson disease (PD) is a neurological degenerative disorder common among the elderly. Neuroinflammation leads to neurodegeneration, which is regulated by the peripheral adaptive immunity. This review discusses the regulatory roles of neuroinflammation by CD4 + T cell subsets (T helper [Th] cell 1, Th2, Th17, Th9, and regulatory T cells). First, we emphasized the roles and mechanisms of CD4 + T cell subsets, as well as the cytokines they secrete, in PD. Second, we explore the associations between helper T cells, regulatory T cells, core cytokines (interleukin 2, 6, 8, tumor necrosis factor-α, interferon-γ), and chemokines (monocyte chemoattractant protein-1) and PD and clarify the role of peripheral inflammation in disease progression. Finally, analyzing the operation of CD4 + T cell subsets in the nervous system will facilitate the development of new therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.